Cargando…
Endocardial Radiofrequency Ablation vs. Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis
BACKGROUND: Septal myectomy (SM) has been the gold standard therapy for most patients with hypertrophic obstructive cardiomyopathy (HOCM). Endocardial radiofrequency ablation of septal hypertrophy (ERASH) is a novel treatment for septal reduction. We aimed to assess the efficacy and safety between t...
Autores principales: | Jiang, Tao, Huang, Bingyu, Huo, Shengqi, Mageta, Lulu Monica, Guo, Junyi, Lv, Jiagao, Lin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086505/ https://www.ncbi.nlm.nih.gov/pubmed/35558385 http://dx.doi.org/10.3389/fsurg.2022.859205 |
Ejemplares similares
-
From 100 to 0: Endocardial Radiofrequency Ablation of Septal Hypertrophy for Management of Hypertrophic Cardiomyopathy
por: Peigh, Graham, et al.
Publicado: (2020) -
Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy
por: Aksu, Tolga, et al.
Publicado: (2016) -
Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
por: Yang, Qiulan, et al.
Publicado: (2021) -
Extended myectomy in the treatment of patients with hypertrophic obstructive cardiomyopathy
por: Kuć, Mateusz, et al.
Publicado: (2016) -
Robotic septal myectomy for hypertrophy cardiomyopathy
por: Cheng, Bor-Chih, et al.
Publicado: (2022)